Categories: All News

News: Apotex Corp Recalls Enoxaparin Sodium Injection USP due to Mislabelling of Syringe Barrel Measurement Markings

The National Agency for Food and Drug Administration and Control (NAFDAC) has received information from the US FDA that Apotex Corp is voluntarily recalling two (2) batches of Enoxaparin Sodium Injection, USP due to a packaging error resulting in some syringes barrels containing 150 mg/mL markings (corresponding to 120 mg/0.8mL strength) instead of 100 mg/mL markings (corresponding to 100 mg/mL strength) on the syringe barrel and vice versa.


Enoxaparin Sodium injection is indicated for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), Treatment of Acute Deep Vein Thrombosis, prophylaxis of ischemic complications of unstable angina and non-Q-wave myocardial infarction, when concurrently administered with aspirin and Treatment of Acute ST-Segment Elevation Myocardial Infarction.

Incorrect syringe barrel marking could lead to miscalculation and inaccurate dose administration to patients. Accidental overdosage following administration of enoxaparin sodium injection may lead to bleeding complications. Alternatively, if the dose administered is less than prescribed, the patient may be subject to developing some blood clotting conditions.

Product details

The affected Enoxaparin Sodium Injection, USP is manufactured by manufactured by Gland Pharma Limited, Hyderabad, India and has the following details:

Product Enoxaparin Sodium Injection, USP
Batch # CS008 CT003
Strength 100 mg/mL 120 mg/0.8mL
Syringe Barrel Measurement Markings 100 mg/mL 150 mg/ mL
Pack Size 10 x 1mL Single Dose Syringes 10 x 0.8 mL Single Dose Syringes
NDC Number on Carton 60505-0795-4 60505-0796-4
NDC Number On label 60505-0795-1 60505-0796-0
UPC Code on Carton 360505079544 360505079643
UPC Code on label (01)10360505079510 (01)10360505079602

Recommendations


Healthcare providers with an existing stock of the recalled products are encouraged to:

  • Stop dispensing or distributing the products immediately and quarantine the products.
  • Return unused products to the nearest NAFDAC office for regulatory action.
Vivian Omotori

Recent Posts

Lagos consumer protection agency recovers about N40 million for consumers within 1 month

The Lagos State Consumer Protection Agency (LASCOPA) has assisted some consumers to recover about N40… Read More

February 25, 2021

LAGOS GOVT. SHUTS 16 ILLEGAL, SUBSTANDARD PHARMACIES, PATENT MEDICINE STORES

Lagos State Taskforce on Counterfeit, Fake Drugs and Unwholesome Processed Foods has shut 16 illegal,… Read More

February 25, 2021

LASUBEB GETS SUPPORT TO CURB SPREAD OF COVID-19 IN PUBLIC PRIMARY SCHOOLS

In order to stem the spread of COVID-19 pandemic amongst learners and stakeholders in Schools,… Read More

February 25, 2021

Lagos law reform commission to update obselete laws

The newly appointed Executive Secretary of Lagos State Law Reform Commission (LAWRECOM), Mrs. Umul-Kulthum Ninilomo… Read More

February 25, 2021

LAGOS COMMENCES PHASED REFURBISHMENT OF GENERAL HOSPITALS

… As Commissioner for Health Inspects Two GHs Undergoing Renovation In line with the current… Read More

February 25, 2021

LAGOS PARTNERS USAID TO IMPROVE LANGUAGE LITERACY IN SCHOOLS

As part of efforts to encourage the teaching and learning of languages in schools, especially… Read More

February 25, 2021

This website uses cookies.